Nyxoah SA
NYXH
View Detailed Chart
4.790USD
-0.060-1.24%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
179.84MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.24%
5 Days
+1.27%
1 Month
+3.68%
6 Months
-37.87%
Year to Date
-40.13%
1 Year
-40.20%
View Detailed Chart
TradingKey Stock Score of Nyxoah SA
Currency: USD Updated: 2025-12-19Key Insights
Nyxoah SA's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 111/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 12.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Nyxoah SA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
6
analysts
Strong Buy
Current Rating
12.000
Target Price
+142.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Nyxoah SA Highlights
StrengthsRisks
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 46.64% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.17M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4.17M.
Overvalued
The company’s latest PE is -2.54, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 8.21M shares, decreasing 19.87% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.28.
Nyxoah SA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Nyxoah SA Info
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Ticker SymbolNYXH
CompanyNyxoah SA
CEOTaelman (Olivier)
Websitehttps://www.nyxoah.com/
FAQs
What is the current price of Nyxoah SA (NYXH)?
The current price of Nyxoah SA (NYXH) is 4.790.
What is the symbol of Nyxoah SA?
The ticker symbol of Nyxoah SA is NYXH.
What is the 52-week high of Nyxoah SA?
The 52-week high of Nyxoah SA is 11.150.
What is the 52-week low of Nyxoah SA?
The 52-week low of Nyxoah SA is 3.840.
What is the market capitalization of Nyxoah SA?
The market capitalization of Nyxoah SA is 179.84M.
What is the net income of Nyxoah SA?
The net income of Nyxoah SA is -59.24M.
Is Nyxoah SA (NYXH) currently rated as Buy, Hold, or Sell?
According to analysts, Nyxoah SA (NYXH) has an overall rating of --, with a price target of 12.000.
What is the Earnings Per Share (EPS TTM) of Nyxoah SA (NYXH)?
The Earnings Per Share (EPS TTM) of Nyxoah SA (NYXH) is -1.911.
Related Instruments
-0.68%
-0.20%
+1.37%
+1.29%
+1.43%
+0.86%
+0.35%
-0.93%
-0.19%
+0.78%
+1.07%
+1.35%
-0.31%
+0.25%
+0.59%
+0.99%
+0.74%
+0.93%
+1.27%
+0.65%
